Categories
Editorial

OMNY Health platform surpasses 50 million patient lives after recent expansion in provider system network coverage

This continued growth will expand the scope of research opportunities, which will result in more life-changing innovation to meet patients’ unmet needs. 

ATLANTA, GA, May 31, 2022 – Today, OMNY Health announced that it has reached a milestone in building its national platform of de-identified clinical data from provider systems, representing over 50 million patients receiving care over the past five years. Much of this growth is attributed to the addition of several large health systems and specialty practice networks that recently joined OMNY Health’s ecosystem. The OMNY Health platform of data includes care delivered in both inpatient and outpatient settings across a variety of provider organizations that is utilized to advance patient-focused research.  Basic electronic health record (EHR) data is augmented with data from a variety of systems within the provider organization including lab systems and imaging and third-party data sources such as claims data to provide a holistic view into the patient experience. This granular data follows the patient journeys of these 50 million+ patients across the care continuum for five or more years.  

“As a physician who has dedicated his career to transforming healthcare, it has always been my vision to build a national data ecosystem that helps connect healthcare providers with researchers, but more importantly, to impact the lives of patients. This expansion is validation that we are on course to achieving that goal. Although we have plenty of opportunity and intend to continue to grow and expand, this marks an exciting milestone for OMNY Health.” said Mitesh Rao, MD, CEO, OMNY Health.  

For provider organizations and their patients, the appeal to joining the OMNY Health network is multi-faceted and presents a number of unique benefits: 

  • Alignment of research opportunities. OMNY Health enables healthcare and research organizations to compliantly explore the breadth and depth of data available to identify and align the right patients for various research initiatives, including opportunities to participate in clinical trials, patient surveys, and quality improvement initiatives.  
  • Maximizing data utilization. OMNY Health facilitates more opportunities for each healthcare organization to utilize data at scale. These organizations work closely with OMNY Health to reinforce their internal data usage through better data capture, reporting, and conversion of data into insights. In addition, they rely on OMNY Health to manage relationships with external parties who require access to vetted de-identified real world data. 
  • Enhancing the patient experience. Whether a healthcare provider or researcher, all parties participating in the OMNY Health ecosystem are aligned on a singular goal of improving patient care through innovation. Regardless of how the healthcare provider engages, OMNY Health impacts patient outcomes by focusing on major disease groups that touch large patient populations within broader therapeutic areas, such as dermatology and ophthalmology, while also being able to reach those with rare diseases.

The ever-increasing breadth, depth, and diversity of the OMNY network will allow healthcare providers and researchers to participate in research at scale and accelerate new and improved medical innovations and treatments that help address disparities in health equity. 

About OMNY Health

The OMNY Health ecosystem features a wide range of products that compliantly facilitate collaboration between researchers and providers while maintaining patient privacy. Serving as a key resource and central intermediary, OMNY Health minimizes the effort required by providers and life sciences organizations to achieve these objectives. By aligning the goals of all sides and forging relationships to provide unique, curated data sets and mechanisms to establish compliant partnerships, OMNY Health fuels innovation where patients need it the most. For more information or to join the OMNY Health network, please contact us.

Categories
Editorial

OMNY Health launches ophthalmology-centric real-world data platform in partnership with leading ophthalmology practices focused on improving patient outcomes

In alignment with OMNY Health’s mission to deliver data and insights to accelerate life-changing innovation, these solutions will serve as a catalyst for research and improved outcomes for the 2+ billion individuals impacted by ophthalmic disease

ATLANTA, GA, May 10, 2022 – Today, OMNY Health announced that it has partnered with the nation’s leading community-based ophthalmology practices to launch a first-of-a-kind, real-world data ecosystem focused on driving collaborative research partnerships to advance treatments and improve outcomes in patients with ophthalmic disorders.  Derived from electronic health record data, OMNY solutions provide valuable information on the evolving treatment paradigm for patients with ophthalmic disease, including difficult to obtain insights on the rationale behind treatment decisions, and the impact of social determinants of health on care delivery and outcomes.  De-identified images from retinal scans and other images also are available from ecosystem partners, allowing researchers to view physical changes in condition severity over time.

A diverse set of providers are participating in the ecosystem, from large independent ophthalmology group practices to academic medical centers, integrated delivery networks, specialty hospitals, and regional health systems.  Practices participating in the OMNY ecosystem will leverage OMNY’s platform to opt into clinical trials, prospective observational surveys, and other collaborative research opportunities.

“We are thrilled to welcome our new ophthalmology providers to our network. Over the past year, we have made great strides connecting researchers and providers in the dermatology space and are looking forward to making the same level of impact on ophthalmology,” said Mitesh Rao, MD, CEO, OMNY Health.

“US Eye looks forward to continuing to strengthen our partnership with OMNY Health and find new ways to leverage our data internally,” said Kinga Huse, President, US Eye. “The ability to make more data-driven decisions that improve outcomes and the patient experience will be a valuable asset for our providers and patients.”

“We are excited to have a partner in OMNY that chose to prioritize Ophthalmology. As a data driven organization, we view this partnership as a conduit to leverage our data to gain new insights in providing care for our patients. The added visibility into additional clinical research opportunities will allow our providers to continue their focus on finding new ways to care for and treat our patients in their efforts to preserve sight,” said Amy Goodson-Burke, Chief Revenue Officer, American Vision Partners.

“As a leading administrative services provider for top notch ophthalmology practices, Sight Growth Partners’ primary focus is to listen to our doctors and provide support for them so they can care for their patients in a better way. We are partnering with OMNY Health to do exactly that…exceed our physician’s needs so they can exceed their patient’s needs,” said Jonathan Lujan, CEO, Sight Growth Partners.

“We are thrilled to be a part of the OMNY Health network. It will allow us to better understand our patient populations, obtain more insight into the impact of care patterns on outcomes, and better align clinical trial opportunities with specific patient cohorts,” said David Shoemaker, MD, Founder and CEO, US Eye.

With an uptick in ophthalmology drug research and approvals in the past few years, researchers can utilize this data to expedite clinical trial recruitment and design, understand evolving treatment patterns, assess trends in healthcare resource utilization, understand current gaps in care, conduct comparative effectiveness studies, and partner with ophthalmology practices around joint missions focused on quality improvement and patient outcomes.

Key populations available in the dataset include dry eye (296K patients), dry age-related macular degeneration (AMD) (109K patients), wet AMD (31K patients), and diabetic retinopathy (64K patients). This unique data asset also includes populations with rare eye diseases such as Stargardt Disease and pediatric populations with congenital disease.

Like other OMNY Health specialty-focused databases, the ophthalmology data set also includes information on pharmacy orders, lab results, medical device detail for implants, and detailed provider clinical assessment measures such as best corrected visual acuity and intraocular pressure values. OMNY will be conducting ophthalmology solution demonstrations and presenting results from studies during a variety of events this summer, including ISPOR, DIA, and ICPE.

About OMNY Health

OMNY Health connects patients, providers, and life sciences companies through data and insights to transform healthcare delivery, improve clinical outcomes, and address patients’ unmet needs. Our platform, representing more than 35M patients, enables turnkey research and the ability to convert insights to actions for over 150 disease areas across more than 115,000 providers.

In addition to its ophthalmology data-centered solutions, the OMNY Health ecosystem features a wide range of products that compliantly facilitate collaboration between researchers and providers while maintaining patient privacy. Serving as a key resource and central intermediary, OMNY Health minimizes the effort required by providers and life sciences organizations to achieve these objectives. By aligning the goals of all sides and forging relationships to provide unique, curated data sets and mechanisms to establish compliant partnerships, OMNY Health fuels innovation where patients need it the most.

For more information, go to www.marketing-dev.omnyhealth.com or email lifesciences@omnyhealth.com.

MEDIA INQUIRIES:  please contact Stacey Long, stacey@omnyhealth.com

View full press release